VAP Are strict diagnostic criteria advisable?

Size: px
Start display at page:

Download "VAP Are strict diagnostic criteria advisable?"

Transcription

1 VAP Are strict diagnostic criteria advisable? Javier Garau, MD, PhD 18th Infection and Sepsis Symposium, Porto, 27th February 2013

2 Limitations of current definitions Alternatives -Streamlined definition of VAP -VAC (?) - New molecular methods for microbiological diagnosis Conclusions

3 Limitations of current definitions of VAP 2 major limitations of the standard VAP definition by the CDC: (1) many of the diagnostic criteria are very subjective (2) the definition correlates poorly with histological pneumonia Interpretation of these criteria is at the discretion of the physician; reasonable observers are likely to arrive at different conclusions and hence very different VAP rates. Beyersmann J et al. Infect Cont Hosp Ep 2006 Klompas M. Am J Infect Control 2010 Schurink CA et al. Intens Care Med 20046

4 Numbers of patients with VAP and selected clinical features among 50 medicalsurgical intensive care patients according to 4 different observers Interobserver variability in the assessment of ventilator-associated pneumonia is high. Komplas M. Am J Infect Control 2010

5 Interobserver agreement between three infection control personnel on the assessment for VAP in 50 medical-surgical intensive care patients Agreement defined as the total number of patients where the observers agreed on the presence and absence of the clinical finding. Klompas M. Am J Infect Control 2010

6 Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with VAP Forest plot of comparison: Quantitative vs qualitative culture, outcome: Mortality Burton DC et al. Cochrane Database of Systematic Reviews 2012

7 Pulmonary Infiltrates The requirement for radiographic evidence has been identified as the most problematic because the interpretations of radiographs and the language used in reporting radiographic findings vary within and among institutions.

8 Ventilator-Associated Pneumonia: Depends on Your Definition Comparison of NNIS Definition of VAP to BAL Diagnosis NNIS missed almost all of the VAPs: the result of the chest x-ray not meeting the initial criteria of the algorithm. This patient population had abnormal chest x-rays at admission or did not have progression of infiltrates. Novosel TJ et al. Am Surgeon 2012

9 It might be possible, however, to improve surveillance objectivity by limiting the definition to objective and quantifiable components. Focusing on objective criteria should also improve efficiency

10 Comparison of Conventional and Streamlined Surveillance Definitions for VAP Komplas M et al. CID 2012

11 Characteristics and Adjusted Outcomes for Patients Included in the Multivariate Analysis Analysis adjusted for hospital, unit type, age, sex, and Charlson index. Faster and more reproducible than the conventional definition and predicts prolongation of MV and intensive care length of stay as effectively as the conventional definition. Komplas M et al. CID 2012

12 VAC The streamlined definition uses similar clinical criteria to the conventional definition and therefore is likely equally prone to mislabel VAP It might make more sense to focus surveillance and benchmarking on the syndrome of ventilator-associated complications in general rather than on pneumonia in particular Efforts focused on creating a new outcome measure for mechanically ventilated patients that captures ventilator associated, pneumonia-like events in a way that is reliable, objective, clinically meaningful, and straightforward. Komplas M et al. CID 2012

13 VAC We retrospectively assessed patients on mechanical ventilation for 48 hours in our study ICU VAC was defined as a sustained increase in ventilator settings after a period of stable or decreasing ventilator support. Subjective measures such as radiographic interpretations are not part of this definition Using electronic medical record data. We analyzed the association between VAC and clinical diagnoses, ICU length of stay, duration of mechanical ventilation, antibiotic use, and mortality. Hayashi Y et al. CID 2013

14 VAC-DEFINITION 2 days of stable or decreasing daily minimum PEEP or FiO 2 followed by a rise in daily minimum PEEP by 2.5 cm H2O lasting 2 days or a rise in daily minimum FiO 2 by 15% lasting 2 days Komplas M et al. PLoS One 2011

15 Descriptive Statistics on Outcomes by Ventilator- Associated Complication Status Data are mean (standard deviation), median, unless otherwise specified. Please note that these data are descriptive only and formal comparison of the groups is not appropriate because of the time-dependent nature of ventilatorassociated complications status. Hayashi Y et al. CID 2013

16 Consumption of Selected Antibiotics During the Stay in ICU by Ventilator-Associated Complication Status Hayashi Y et al. CID 2013

17 VAC events were due to: - Potential VAP (VAC with positive culture of respiratory pathogens in respiratory specimens plus antibiotic prescription with intention to treat as VAP by intensivist) in 30.7% - Atelectasis in 16.3% - Acute pulmonary edema in 11.8% - ARDS in 6.5%. VAC events were associated with significantly increased ICU length of stay, duration of mechanical ventilation, and consumption of broad-spectrum antibiotics but not with longer hospital stays or ICU mortality. Hayashi Y et al. CID 2013

18 VAC We believe that VAC is a more suitable surveillance target in patients on mechanical ventilation than VAP We support calls for improved diagnostic methods (such as the use of pneumonia specific biomarkers) for VAP Hayashi Y et al. CID 2013

19 Validation of a novel high multiplexing real-time PCR array for the identification of key pathogens causative of VAP and their associated R genes Rapid diagnosis and appropriate empirical antimicrobial therapy is of pivotal importance for the clinical outcome of VAP.. The Real-time Array PCR for Infectious Diseases (RAP-ID) is a novel technology that combines multiplex PCR with real-time microarray detection. The VAPChip is a closed cartridge kit adapted to the RAP-ID instrument that targets 13 key respiratory pathogens causative of VAP and 24 relevant antimicrobial resistance genes to B-lactams. Validation VAPChip was carried out on a collection of 292 genotypically characterized bacterial reference and clinical isolates (including 67 bacterial isolates belonging to the oropharyngeal flora not targeted by the array) The limit of detection of the assay lies between 10 and 100 genome copies/pcr and the dynamic range is five orders of magnitude permitting at least semi-quantitative reporting of the results. Sensitivity, specificity and negative and positive predictive values ranged from 95.8% to 100% for species identification and detection of resistance genes. Conclusions: VAPChip is a novel diagnostic tool able to identify resistant bacterial isolates by RAP-ID technology. The results of this analytical validation have to be confirmed on clinical specimens. Bogaerts P et al. JAC 2013

20 List of the targets detected by the VAPChip assay Bogaerts P et al. JAC 2013

21 Repertoire of Intensive Care Unit Pneumonia Microbiota To highlight the different compositions of microbiota in patients with four different types of ICU-pneumonia. 185 episodes of ICU pneumonia and 25 control cases. Using 16S rdna gene amplification followed by clone libraries sequencing.they also used specific quantitative PCR. (qpcr) to target fastidious bacteria and a spectrum of viruses. Moreover, they tested samples from our patients by standardized routine culture, amoebal co-culture, blood culture, ELISA targeted antibody detection, immunofluorescent assay antigenemia and antigenuria testing as routinely performed in such cases to compare these routine tests with molecular approaches Bousbia S et al. PLoS ONE 2012

22 Summary of the number of bacteria, fungi and viruses identified by molecular assays in BAL fluids Bousbia S et al. PLoS One 2012

23 Results Overall, patients exhibited 146 different species belonging to 7 different phyla (13 classes, 23 orders, 44 families and 71 genera) of which 73 had not been previously observed in BAL from pneumonia, whereas bacterial clone libraries of controls identified 38 species belonging to 4 different phyla (9 classes, 13 orders, 22 families and 27 genera). Moreover, 51 strictly anaerobic bacteria (35%) were found in patients versus 17 anaerobic bacteria (44%) found in controls (p=0.26) Bousbia S et al. PLoS One 2012

24 The phylogenetic tree inferred from bacterial 16S rdna sequences which were identified in all patients using the Neighbor-Joining and the Kimura 2-parameter methods Bacteria previously identified in pneumonia are shown in black. Bacteria previously identified in pneumonia and which were identified in this study only in pneumonia patients are shown in red. Bacteria not previously identified in pneumonia patients and which were identified in this study in both pneumonia and control patients are shown in blue, Bacteria which have been identified in this study only in control subjects and not in pneumonia patients are shown in green

25 Differences in bacterial microbiota composition between community- acquired pneumonia (CAP), ventilator-associated pneumonia (VAP), non-ventilator ICU pneumonia (NV ICU-P), aspiration pneumonia (AP) and control subjects (CS) cohorts. Bousbia S et al. PLoS One 2012

26 Our results demonstrate that nearly 50% of the microbial species found had not been previously reported in lung samples from pneumonia. Therefore, the composition of ICUpneumonia microbiota is more complex, more extensive and more diverse than originally expected. Bousbia S et al. PLoS One 2012

27 Conclusions Diagnosis of VAP and its etiology is essential if we are to rationalise its management None of the available diagnostic tests, performed alone, can provide an accurate diagnosis of VAP. A diagnostic strategy incorporating several criteria seems to be a good compromise. Further evaluation by imaging procedures, microbiological cultures, and pneumonia specific biomarkers to refine the probability of diagnosing VAP - Limiting the definition to objective and quantifiable components. - Systematic use of microbiological methods - Non-invasive vs. Invasive techniques - Systematic use of quantitative techniques - Explore other image diagnostic modalities Incorporate rapid, molecular quantitative diagnostics VAC is a good tool for surveillance purposes but is not going to improve our diagnostic ability of VAP

New Surveillance Definitions for VAP

New Surveillance Definitions for VAP New Surveillance Definitions for VAP 2012 Critical Care Canada Forum Toronto Dr. John Muscedere Associate Professor of Medicine, Queen s University Kingston, Ontario Presenter Disclosure Dr. J. G. Muscedere

More information

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong

More information

Lâcher les VAP pour les VAC, les IVAC?...(CDC) INTRODUCTION

Lâcher les VAP pour les VAC, les IVAC?...(CDC) INTRODUCTION Lâcher les VAP pour les VAC, les IVAC?...(CDC) lila.bouadma@bch.aphp.fr INTRODUCTION VAP surveillance is needed to measure incidence and to gauge the success of prevention efforts. However, VAP diagnosis

More information

Ventilator associated events, conditions and prevention of VAP. Dr.Pratap Upadhya

Ventilator associated events, conditions and prevention of VAP. Dr.Pratap Upadhya Ventilator associated events, conditions and prevention of VAP Dr.Pratap Upadhya Introduction Pathogenesis of vap Diagnosis of vap Ventilator-Associated Events: New Terminology and Its Relationship to

More information

Guidelines. 14 Nov Marc Bonten

Guidelines. 14 Nov Marc Bonten Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.

More information

Clinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention

Clinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Clinical for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Background Ventilator-associated pneumonia (VAP), a pneumonia that develops 48hrs after initiation of mechanical ventilation,

More information

Community Acquired & Nosocomial Pneumonias

Community Acquired & Nosocomial Pneumonias Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP

More information

Hospital-acquired Pneumonia

Hospital-acquired Pneumonia Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired

More information

Invasive Pulmonary Aspergillosis in

Invasive Pulmonary Aspergillosis in Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,

More information

Herpes virus reactivation in the ICU. M. Ieven BVIKM

Herpes virus reactivation in the ICU. M. Ieven BVIKM Herpes virus reactivation in the ICU M. Ieven BVIKM 07.04.2011 Introduction: Viruses identified in critically ill ICU patients Viral diseases have recently been the subject of numerous investigations in

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health

More information

VAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland.

VAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland. VAP in COPD patients Ignacio Martin-Loeches St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland. Outline Pathophysiology Is enough information? COPD trends in ICU How do

More information

Ventilator-Associated Event (VAE) For use in adult locations only

Ventilator-Associated Event (VAE) For use in adult locations only Ventilator-Associated Event () For use in adult locations only Table of Contents: Introduction 1 Settings 3 Definitions 3 Reporting Instructions 16 Figures 1-4, Algorithm 18 Numerator Data 23 Denominator

More information

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,

More information

Ventilator Associated

Ventilator Associated Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,

More information

Current and Emerging Legionella Diagnostics

Current and Emerging Legionella Diagnostics Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape

More information

Antimicrobial Stewardship in Community Acquired Pneumonia

Antimicrobial Stewardship in Community Acquired Pneumonia Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis

More information

Challenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia

Challenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia Challenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia Massachusetts Coalition for the Prevention of Errors November 6, 2008 Michael Klompas MD, MPH, FRCPC Brigham and

More information

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics Deborah Cook Objectives VAP The Old: Gastropulmonary route of infection The New: Microbiome modification Role of acid suppression Influence

More information

Ventilator Associated Pneumonia: New for 2008

Ventilator Associated Pneumonia: New for 2008 Ventilator Associated Pneumonia: New for 2008 Jeanine P. Wiener-Kronish, MD Henry Isaiah Dorr Professor of Research and Teaching in Anaesthetics and Anaesthesia Department of Anesthesia and Critical Care

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical

More information

Research & Reviews of. Pneumonia

Research & Reviews of. Pneumonia Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *

More information

Pneumonia in the Hospitalized

Pneumonia in the Hospitalized Pneumonia in the Hospitalized Patient: Use of Steroids Nicolette Myers, MD Pulmonary/Sleep/Critical Care November 9, 2018 Park Nicollet Clinic Facts About Pneumonia CAP is the 8 th most common cause of

More information

Landmark articles on ventilation

Landmark articles on ventilation Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP

More information

ANWICU knowledge

ANWICU knowledge ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted

More information

Influenza-Associated Pediatric Deaths Case Report Form

Influenza-Associated Pediatric Deaths Case Report Form STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State

More information

Understanding Non-Ventilator-Associated Pneumonia and Other Lower Respiratory Infections Isaac See, MD November 7, 2013

Understanding Non-Ventilator-Associated Pneumonia and Other Lower Respiratory Infections Isaac See, MD November 7, 2013 Understanding Non-Ventilator-Associated Pneumonia and Other Lower Respiratory Infections Isaac See, MD November 7, 2013 National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare

More information

infection control and hospital epidemiology january 2008, vol. 29, no. 1 original article

infection control and hospital epidemiology january 2008, vol. 29, no. 1 original article infection control and hospital epidemiology january 2008, vol. 29, no. 1 original article Development of an Algorithm for Surveillance of Ventilator-Associated Pneumonia With Electronic Data and Comparison

More information

Is ARDS Important to Recognize?

Is ARDS Important to Recognize? Is ARDS Important to Recognize? Lorraine B. Ware MD Vanderbilt University Financial Disclosures: research funding from Boehringer Ingelheim, Global Blood Therapeutics Why diagnose ARDS? -initiate specific

More information

Potential Conflicts of Interests

Potential Conflicts of Interests Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly

More information

The Berlin Definition: Does it fix anything?

The Berlin Definition: Does it fix anything? The Berlin Definition: Does it fix anything? Gordon D. Rubenfeld, MD MSc Professor of Medicine, University of Toronto Chief, Program in Trauma, Emergency, and Critical Care Sunnybrook Health Sciences Centre

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

How do we define pneumonia?

How do we define pneumonia? Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever

More information

Rapid and Reproducible Surveillance for Ventilator-Associated Pneumonia

Rapid and Reproducible Surveillance for Ventilator-Associated Pneumonia MAJOR ARTICLE Rapid and Reproducible Surveillance for Ventilator-Associated Pneumonia Michael Klompas, 1,2 Ken Kleinman, 1 Yosef Khan, 3 R. Scott Evans, 4,5 James F. Lloyd, 5 Kurt Stevenson, 3 Matthew

More information

Trial protocol - NIVAS Study

Trial protocol - NIVAS Study 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery

More information

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,

More information

Lecture Notes. Chapter 16: Bacterial Pneumonia

Lecture Notes. Chapter 16: Bacterial Pneumonia Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment

More information

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care

More information

Top 5 papers in clinical mycology

Top 5 papers in clinical mycology Top 5 papers in clinical mycology Dirk Vogelaers Department of General Internal Medicine University Hospital Ghent Joint symposium BVIKM/BSIMC and SBMHA/BVMDM Influenza-associated aspergillosis in critically

More information

CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP

CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP ERIN H. GRAF, PHD, D(ABMM) Director, Infectious Disease Diagnostics Laboratory Assistant Professor, Clinical Pathology and

More information

Preventing & Controlling the Spread of Infection

Preventing & Controlling the Spread of Infection Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known

More information

UPDATE IN HOSPITAL MEDICINE

UPDATE IN HOSPITAL MEDICINE UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some

More information

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine Best of Pulmonary 2012-2013 Jennifer R. Hucks, MD University of South Carolina School of Medicine Topics ARDS- Berlin Definition Prone Positioning For ARDS Lung Protective Ventilation In Patients Without

More information

ICU management and referral guidelines for severe hypoxic respiratory failure

ICU management and referral guidelines for severe hypoxic respiratory failure Aim: ICU management and referral guidelines for severe hypoxic respiratory failure 1) To provide a concise management plan Non ventilatory Ventilatory 2) Timeline for referring patient with refractory

More information

Understanding the NHSN Ventilator Associated Event (VAE) Definition

Understanding the NHSN Ventilator Associated Event (VAE) Definition Understanding the NHSN Ventilor Associed Event (VAE) Definition Disclosures Honorarium from Sage Shilla Pel OD, CIC Clinical Epidemiologist Scripps Mercy San Diego Objectives Learn how to use the new VAE

More information

From the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital

From the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures

More information

Cytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia

Cytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia Cytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia I.P. Lodding 1,2, H.H. Schultz 3, J.U. Jensen 1,5, C. Andersen 4,

More information

The new ARDS definitions: what does it mean?

The new ARDS definitions: what does it mean? The new ARDS definitions: what does it mean? Richard Beale 7 th September 2012 METHODS ESICM convened an international panel of experts, with representation of ATS and SCCM The objectives were to update

More information

PULMONARY EMERGENCIES

PULMONARY EMERGENCIES EMERGENCIES I. Pneumonia A. Bacterial Pneumonia (most common cause of a focal infiltrate) 1. Epidemiology a. Accounts for up to 10% of hospital admissions in the U.S. b. Most pneumonias are the result

More information

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions

More information

Bayesian Networks in Medicine: a Model-based Approach to Medical Decision Making

Bayesian Networks in Medicine: a Model-based Approach to Medical Decision Making Bayesian Networks in Medicine: a Model-based Approach to Medical Decision Making Peter Lucas Department of Computing Science University of Aberdeen Scotland, UK plucas@csd.abdn.ac.uk Abstract Bayesian

More information

Sepsis: What Is It Really?

Sepsis: What Is It Really? Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami

More information

MICROBIOLOGICAL TESTING IN PICU

MICROBIOLOGICAL TESTING IN PICU MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes

More information

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk

More information

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE

More information

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

The Potential For Microbiome Modification In Critical Illness. Deborah Cook The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September

More information

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience

More information

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

More information

without the permission of the author Not to be copied and distributed to others

without the permission of the author Not to be copied and distributed to others Emperor s Castle interior-prato What is the Role of Inhaled Polymyxins for Treatment of Respiratory Tract Infections? Helen Giamarellou CONCLUSIONS: Patients with Pseudomonas and Acinetobacter VAP may

More information

ARDS during Neutropenia. D Mokart DAR IPC GRRRRROH 2010

ARDS during Neutropenia. D Mokart DAR IPC GRRRRROH 2010 ARDS during Neutropenia D Mokart DAR IPC GRRRRROH 2010 Definitions Neutropenia is a decrease in circulating neutrophil white cells in the peripheral blood. neutrophil count of 1,000 1,500 cells/ml = mild

More information

DAILY SCREENING FORM

DAILY SCREENING FORM DAILY SCREENING FORM Patient s initials: Date of admission: Time of admission: Gender: M F Year of Birth: Type of admission: Medical/Surgical/Postoperative (elective) Days Date Mechanical ventilation Lung

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018

More information

Human Infection with Novel Influenza A Virus Case Report Form

Human Infection with Novel Influenza A Virus Case Report Form Human Infection with Novel Influenza A Virus Case Report Form Form Approved OMB No. 0920-0004 Exp. Date 6/30/2013 Reporter Information State: Date reported to state/local health department: / / (MM/DD/YYYY)

More information

Infection Control. Craig M Coopersmith, MD

Infection Control. Craig M Coopersmith, MD Infection Control Craig M Coopersmith, MD Professor of Surgery Director, Surgical Intensive Care Unit Associate Director Emory Center for Critical Care Financial disclosure I have received grant support

More information

Avian Influenza Clinical Picture, Risk profile & Treatment

Avian Influenza Clinical Picture, Risk profile & Treatment Avian Influenza Clinical Picture, Risk profile & Treatment Jantjie Taljaard Adult ID Unit Tygerberg Academic Hospital University of Stellenbosch jjt@sun.ac.za 083 419 1452 CLINICAL PICTURE The clinical

More information

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES 1 Marin H. Kollef, MD Professor of Medicine Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine Washington University School of

More information

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory

More information

VAP Prevention bundles

VAP Prevention bundles VAP Prevention bundles Dr. Shafiq A.Alimad MD Head of medical department at USTH YICID workshop, 15-12-2014 Care Bundles What are they & why use them? What are Care Bundles? Types of Care Bundles available

More information

Annual Surveillance Summary: Clostridium difficile Infections in the Military Health System (MHS), 2016

Annual Surveillance Summary: Clostridium difficile Infections in the Military Health System (MHS), 2016 Annual Surveillance Summary: Clostridium difficile Infections in the Military Health System (MHS), 2016 Charlotte Neumann and Uzo Chukwuma Approved for public release. Distribution is unlimited. The views

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Cytomegalovirus in critically ill patients

Cytomegalovirus in critically ill patients ! Cytomegalovirus in critically ill patients Frédéric Pène Medical ICU, Hôpital Cochin, AP-HP, Paris, France Université Paris Descartes, Sorbonne Paris Cité Institut Cochin, Inserm U1016, CNRS UMR-8104

More information

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important

More information

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical

More information

Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS

Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS M. Luchetti, E. M. Galassini, A. Galbiati, C. Pagani,, F. Silla and G. A. Marraro gmarraro@picu.it www.picu.it Anesthesia and Intensive Care

More information

Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography

Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography CHEST 2014; 146(6): 1578-1585 文献精读 Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography Giovanni Zagli, MD, PhD ; Morena

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Microarray-based Gene Expression Testing for Cancers of Unknown File Name: Origination: Last CAP Review: Next CAP Review: Last Review: microarray-based_gene_expression_testing_for_cancers_of_unknown_primary

More information

OSCAR & OSCILLATE. & the Future of High Frequency Oscillatory Ventilation (HFOV)

OSCAR & OSCILLATE. & the Future of High Frequency Oscillatory Ventilation (HFOV) & & the Future of High Frequency Oscillatory Ventilation (HFOV) www.philippelefevre.com What do we know already? Sud S et al. BMJ 2010 & Multi-centre randomised controlled trials of HFOV verses current

More information

VAP Definitions. CDC New Approach to VAP Surveillance. Conflict of Interest Disclosure Robert M Kacmarek. Artificial Airways, Cuffs, Bioflim and VAP

VAP Definitions. CDC New Approach to VAP Surveillance. Conflict of Interest Disclosure Robert M Kacmarek. Artificial Airways, Cuffs, Bioflim and VAP Conflict of Interest Disclosure Robert M Kacmarek Artificial Airways, Cuffs, Bioflim and VAP Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 9-14-18

More information

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Microbiological evaluation: how to report the results Alvaro Pascual MD, PhD Infectious Diseases and Clinical Microbiology Unit. University Hospital Virgen Macarena University of Sevilla BSI management

More information

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance 10 July 2009 Background This document updates the interim WHO guidance on global surveillance of pandemic

More information

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016 Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology

MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology Patrick R. Murray, PhD WW Director, Scientific Affairs BD Diagnostic Systems Outline MALDI-TOF is the most important innovation

More information

Outline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010

Outline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010 Pharmacists Improving Outcomes in the Management of Infectious Diseases Christine Teng, MSc(Clin Pharm) BCPS Assistant Professor Dept of Pharmacy, National University of Singapore Principal Pharmacist

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

The diagnosis of Chronic Pancreatitis

The diagnosis of Chronic Pancreatitis The diagnosis of Chronic Pancreatitis 1. Background The diagnosis of chronic pancreatitis (CP) is challenging. Chronic pancreatitis is a disease process consisting of: fibrosis of the pancreas (potentially

More information

Critical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma

Critical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma - is an acute infection of the pulmonary parenchyma - is a common infection encountered by critical care nurses when it complicates the course of a serious illness or leads to acute respiratory distress.

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author INFLUENZA IN CHILDREN Cristian Launes Infectious Diseases Unit. Department of Paediatrics. Hospital Sant Joan de Déu (Universitat de Barcelona) Innovation in Severe Acute Respiratory Infections (SARI),

More information

PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION.

PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION. Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP)

More information

SEPSIS RESULTING FROM PNEUMONIA FILE

SEPSIS RESULTING FROM PNEUMONIA FILE 13 January, 2018 SEPSIS RESULTING FROM PNEUMONIA FILE Document Filetype: PDF 521.12 KB 0 SEPSIS RESULTING FROM PNEUMONIA FILE Aspiration pneumonia is a type of lung infection. CAP's symptoms are the result

More information

12/1/2017. Disclosures. Objectives. The Microbiome Defined

12/1/2017. Disclosures. Objectives. The Microbiome Defined Can Critical Illness and the Microbiome Play Nice Together? SCOTT BOLESTA, PHARMD, BCPS, FCCM ASSOCIATE PROFESSOR OF PHARMACY PRACTICE, WILKES UNIVERSITY VISITING INVESTIGATOR, GEISINGER HEALTH SYSTEM

More information

ACUTE RESPIRATORY DISTRESS SYNDROME

ACUTE RESPIRATORY DISTRESS SYNDROME ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe

More information